Skip to main content

Human Identification Market Size, Share, Analysis, Emerging Trends, Growth Opportunities, Status Business Outlook 2032

 Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis/profiling being a key tool in this sector. Due to increasing demands on time and resources, human identification and forensics labs are under constant pressure to increase the efficiency of their workflows without sacrificing quality. Examining the variety of biological indicators that are available to investigators illustrates the basic principles of each process in criminal investigation and paternity identification. While DNA and fingerprints are clearly the favored methods of identification, they require a prior record and verifiable baseline for comparison.

The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032. The growth in the global human identification market is expected to be driven by the increasing adoption of NGS in various research fields, high adoption of forensic applications, and technological advancements in the field of molecular techniques and diagnostics tests.

Impact

•   Increasing demand for human identification products/technologies is anticipated to support the growth of the global human identification market during the forecast period 2022-2032.
•   The market is expected to grow at a significant growth rate due to opportunities such as the high adoption of forensic applications in the field of computational biology and technological advancements in the field of molecular techniques and diagnostics tests.

Impact of COVID-19

The current global human identification market comprises various applications such as forensic applications, paternity applications, and other applications. It has been noticed that there has been a reduction in the capacity or shutdowns of laboratories and other research institutions, which has led to reduced usage of various products and services related to research.

The government imposed various restrictions during COVID-19, such as travel bans, quarantines, curfews, business shutdowns, and closures. This led to an increased cost of the COVID-19-related services. There have been many issues during the COVID-19 pandemic, such as operational failures, shipping issues, inaccurate demand forecasts, and other production issues.

Furthermore, the health and the safety of employees were impacted as COVID-19 reduced the efficacy of employees' work potential. However, the market related to COVID-19 grew during the pandemic as customers were in need of testing services. Overall, the impact of COVID-19 on the market size has been low-moderate. Some market players have reported a slight decline in sales. However, financials are already on their way to recovery. The decline in revenues was mostly a result of the initial phases of the COVID-19 pandemic, which comprised complete lockdowns across countries and major cities, thus interrupting the supply chain. The timeline of impact spanned the end of the first quarter and the second quarter of 2020 for most key markets across the globe. However, the pandemic has played a key role in enhancing the growth prospects of human identification and is expected to indirectly aid in improving the market growth outlook.

Market Segmentation:

Segmentation 1: by Offering
•    Product
•    Service

The service segment held the largest share, 55.47%, of the global human identification market in 2021. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 53.00% share in 2032. The high share of the services segment is majorly due to the rising demand for human identification services in paternity testing procedures, the rising number of product launches and approval in recent years, and increasing emphasis on the adoption of human identification technologies.

Segmentation 2: by Technology
•    Next-Generation Sequencing (NGS)
•    Polymerase Chain Reaction (PCR)
•    Capillary Electrophoresis
•    Nucleic Acid Extraction and Purification (Magnetic Bead Technology)
•    Rapid DNA Analysis
•    Other Technologies

In 2021, the global human identification market (by technology) was dominated by PCR, with a massive market share of 41.00%. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 37.11% share in 2032. This is primarily due to the growing incidences of violent crime leading to growth in demand for rapid DNA analysis in forensics testing.

Segmentation 3: by Application
•    Forensic Application
•    Paternity Identification
•    Other Applications

In 2021, the global human identification market (by application) was dominated by forensic applications, with a massive market share of 61.88%. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 62.11% share in 2032.

Segmentation 4: by End User
•    Forensic Laboratories and Law Enforcement Agencies
•    Academic and Research Institutions
•    Hospitals and Healthcare Providers

The forensic laboratories and law enforcement agencies segment dominate the global human identification market. Academic and research institutions are among the primary end-users of human identification. Research organizations constitute integral facilities for companies as well as independent academic research facilities.

Segmentation 5: by Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Rest-of-the-World

The North America region is expected to dominate the global human identification market during the forecast period 2022-2032. North America has a high adoption rate of forensic testing kits and services. Backed by several healthcare companies working in the marketplace, the U.S. has the highest implementation of PCR, NGS, and other technologies. The North America region is expected to reach $3,526.7 million in 2032 from $737.7 million in 2021, at a CAGR of 15.07% during the forecast period.

Recent Developments in the Global Human identification Market

•    Partnership: In 2021, QIAGEN partnered with Verogen, Inc. to provide superior tools and comprehensive support for forensic biometric identification workflows in the laboratories.
•    Product Launch: In 2021, QIAGEN launched the EZ2 Connect Instrument Line that will speed the benefits of biomedical research, forensics, and clinical diagnostics.
•    Product Launch: In 2022, Promega Corporation launched Spectrum CE System for performing human identification in criminal casework and database cases in forensic laboratories.

Human identification Market Dynamics

 

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

•    Abbott.
•    Agilent Technologies, Inc.
•    Bio-Rad Laboratories, Inc.
•    Eurofins Scientific
•    Promega Corporation
•    Illumina, Inc.
•    Laboratory Corporation of America Holdings
•    PerkinElmer Inc.
•    QIAGEN N.V.
•    Thermo Fisher Scientific Inc.
•    Verogen, Inc.
•    NMS Labs
•    AUTOGEN INC.
•    GENETEK BIOPHARMA GmbH
•    SecuriGene Technologies Inc.

 

 

Key Questions Answered in the Report

  • What are the major market drivers, challenges, and opportunities in the global human identification market?
  • What are the key development strategies which are implemented by the major players to sustain in the competitive market?
  • Which is the dominant product type developed by the leading and emerging players for human identification?
  • How is each segment of the market expected to grow during the forecast period from 2022 to 2032? Following are the segments:
  • Offering (product and service)
  • Technology (next-generation sequencing (NGS), polymerase chain reaction (PCR), capillary electrophoresis, nucleic acid extraction and purification (magnetic bead technology), rapid DNA analysis technology, and other technologies)
  • Application (forensic application, paternity identification, and other application)
  • End User (forensic laboratories and law enforcement agencies, academic and research institutions, hospitals, and healthcare providers)
  • Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • From the end-users' point of view, does efficiency or convenience hold the key to driving the global human identification market?

 

BIS Research Related Market Studies:

Global Molecular Forensics Market 

Global Forensic Technology Market

Comments

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p